Skip to main content

Opaleye Management Inc.

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1595855 Boston, MA

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,258,000
+$1,718,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#70
of 341 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. PTGX ranks #21 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,258,000 100,000
2026-03-31 $10,540,000 100,000
2025-12-31 $9,170,700 105,000
2025-09-30 $6,975,150 105,000
2025-06-30 $5,803,350 105,000
2025-03-31 $5,077,800 105,000
2024-12-31 $4,053,000 105,000
2024-09-30 $4,725,000 105,000
2024-06-30 $3,638,250 105,000
2024-03-31 $3,260,411 112,700
2023-12-31 $2,584,211 112,700
2022-03-31 $5,955,520 251,500
2021-12-31 $11,696,400 342,000
2021-09-30 $5,851,533 330,222
2021-06-30 $14,820,363 330,222
2021-03-31 $7,692,300 297,000
2020-12-31 $5,241,600 260,000